By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Advaxis, Inc. 

The Technology Centre of New Jersey
675 U.S. Route One, South
North Brunswick  New Jersey  08902   U.S.A.
Phone: 732-545-1590 Fax: 732-545-1084


SEARCH JOBS

Advaxis is a clinical-stage biotechnology company developing cancer immunotherapies that enlist the body’s own immune system to fight cancer.

YEAR FOUNDED:

2002

LEADERSHIP:

CEO: Daniel O’Connor

CFO: Sara Bonstein

CSO (Scientific): Robert Petit

JOBS:

Please click here for Advaxis job opportunities.

CLINICAL TRIAL:

Please click here for clinical trial information.

FOLLOW ADVAXIS:



Key Statistics


Email:
Ownership: Public

Web Site: Advaxis
Employees:
Symbol: ADXS
 



Industry
Biotechnology






Company News
Advaxis (ADXS) Provides Phase I Data Of Higher Dose Axalimogene Filolisbac 3/27/2017 7:12:42 AM
Advaxis (ADXS) Release: EMA Certification Paves The Way For The MAA Submission For Axalimogene Filolisbac In Metastatic Cervical Cancer 3/23/2017 11:29:44 AM
Advaxis (ADXS) Presents Oral Late-Breaking Data On Phase II GOG-0265 Study Of Axalimogene Filolisbac At SGO’s Annual Meeting On Women’s Cancer 3/15/2017 8:43:37 AM
Advaxis (ADXS) Appoints Al Blunt, M.D., As Its Vice President Of Medical 3/7/2017 8:56:56 AM
Advaxis (ADXS) Announces FDA Acceptance Of IND For Groundbreaking Personalized Neoepitope Immunotherapy, ADXS-NEO 3/6/2017 10:53:54 AM
Advaxis (ADXS), SELLAS Life Sci Ink $358 Million Cancer Immunotherapy R&D Pact 2/27/2017 6:42:19 AM
Advaxis (ADXS) Release: GOG-0265 Study In Metastatic Cervical Cancer Selected For Late-Breaking Data Presentation At The Society Of Gynecologic Oncology’s Annual Meeting On Women’s Cancer 1/30/2017 7:40:23 AM
Advaxis (ADXS) Release: New Published Research Reveals That Cervical Cancer Mortality Rates May Be Significantly Higher In The United States Than Previously Reported 1/25/2017 7:35:40 AM
Advaxis (ADXS) Provides 2017 Business Outlook 1/9/2017 7:41:07 AM
Discussion On Advaxis (ADXS)’ ADXS-NEO, ADXS-HOT Programs Held During The International Congress On Immunotherapies In Cancer 12/12/2016 7:36:42 AM
12345678910...
//-->